2025
SJR Q3
JCR Q4 · 0,7
74 matched articles
SCIE
Journal detail
Pharmazie
- Publisher
- Avoxa – Mediengruppe Deutscher Apotheker GmbH
- Country
- Germany · Western Europe
- Type
- journal
- ISSN
-
00317144
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,231
- Quartile Q3
- H-Index 77
- Cites/doc 0,73
- Docs (3y) 146
- Cites (3y) 127
Clarivate
Web of Science · JCR · 2025
- JCR Q Q4
- JIF 0,7
- 5Y JIF 1,3
- JCI 0,2
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Pharmaceutical Science Q3
Areas
- Pharmacology, Toxicology and Pharmaceutics
WoS categories
- Chemistry, Medicinal | Chemistry, Multidisciplinary | Pharmacology & Pharmacy
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q3 | Q4 | 0,231 | 0,7 | 1,3 | 0,2 | Q3 | 77 |
| 2024 | Q2 | Q4 | 0,398 | 1 | 1,4 | 0,26 | Q3 | 74 |
| 2023 | Q2 | Q3 | 0,372 | 1,5 | 1,4 | 0,29 | Q3 | 74 |
| 2022 | Q3 | Q4 | 0,328 | 1,6 | 1,6 | 0,33 | Q3 | 74 |
| 2021 | Q3 | Q4 | 0,31 | 1,5 | 1,6 | 0,33 | Q3 | 74 |
| 2020 | Q2 | Q4 | 0,351 | 1,3 | 1,4 | 0,34 | Q3 | 74 |
| 2019 | Q2 | Q4 | 0,334 | 1,2 | 1,2 | 0,31 | Q3 | 74 |
| 2018 | — | Q4 | — | 0,8 | 1 | 0,27 | Q3 | — |
| 2017 | Q2 | Q4 | 0,375 | 1 | 1,1 | 0,32 | Q3 | 74 |
| 2016 | Q2 | Q3 | 0,429 | 1,1 | 1,2 | — | — | 74 |
| 2015 | Q2 | Q3 | 0,44 | 1,3 | 1,2 | — | — | 74 |
| 2014 | Q2 | Q3 | 0,433 | 1,1 | 1,1 | — | — | 74 |
| 2013 | Q2 | Q3 | 0,368 | 1 | 0,9 | — | — | 74 |
| 2012 | Q2 | Q3 | 0,364 | 1 | 1 | — | — | 74 |
| 2011 | Q2 | Q3 | 0,335 | 1 | 0,9 | — | — | 74 |
| 2010 | Q2 | Q3 | 0,361 | 0,9 | 0,9 | — | — | 74 |
| 2009 | — | Q3 | — | 0,8 | 0,8 | — | — | — |
| 2008 | — | Q3 | — | 0,9 | 0,9 | — | — | — |
| 2007 | — | Q3 | — | 0,8 | 0,8 | — | — | — |
| 2006 | — | Q3 | — | 0,6 | — | — | — | — |
| 2005 | — | Q3 | — | 0,7 | — | — | — | — |
| 2004 | — | Q3 | — | 0,6 | — | — | — | — |
| 2003 | — | Q3 | — | 0,7 | — | — | — | — |
| 2002 | — | Q3 | — | 0,7 | — | — | — | — |
| 2001 | — | Q3 | — | 0,5 | — | — | — | — |
| 2000 | — | Q3 | — | 0,5 | — | — | — | — |
| 1999 | — | Q3 | — | 0,4 | — | — | — | — |
| 1998 | — | Q3 | — | 0,4 | — | — | — | — |
| 1997 | — | Q3 | — | 0,5 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | CHEMISTRY, MEDICINAL | SCIE | Q4 | Q4 | 72/72 |
| 2025 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q4 | Q3 | 218/250 |
| 2025 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q4 | 333/356 |
| 2024 | CHEMISTRY, MEDICINAL | SCIE | Q4 | Q4 | 67/72 |
| 2024 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q4 | Q3 | 183/239 |
| 2024 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q4 | 305/352 |
| 2023 | CHEMISTRY, MEDICINAL | SCIE | Q4 | Q4 | 57/72 |
| 2023 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q3 | Q3 | 155/231 |
| 2023 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q4 | 265/354 |
| 2022 | CHEMISTRY, MEDICINAL | SCIE | Q4 | Q4 | 55/60 |
| 2022 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q4 | Q3 | 135/178 |
| 2022 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q4 | 242/278 |
| 2021 | CHEMISTRY, MEDICINAL | SCIE | Q4 | Q4 | 58/63 |
| 2021 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q4 | Q3 | 141/179 |
| 2021 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q4 | 252/279 |
| 2020 | CHEMISTRY, MEDICINAL | SCIE | Q4 | Q4 | 56/62 |
| 2020 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q4 | Q3 | 140/178 |
| 2020 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q4 | 253/276 |
| 2019 | CHEMISTRY, MEDICINAL | SCIE | Q4 | Q4 | 56/61 |
| 2019 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q4 | Q3 | 134/177 |
| 2019 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q4 | 244/271 |
| 2018 | CHEMISTRY, MEDICINAL | SCIE | Q4 | Q4 | 58/61 |
| 2018 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q4 | Q3 | 141/172 |
| 2018 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q4 | 245/267 |
| 2017 | CHEMISTRY, MEDICINAL | SCIE | Q4 | Q4 | 54/59 |
| 2017 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q4 | Q3 | 130/171 |
| 2017 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q4 | 232/261 |
| 2016 | CHEMISTRY, MEDICINAL | SCIE | Q4 | — | 51/60 |
| 2016 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q3 | — | 116/166 |
| 2016 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 219/257 |
| 2015 | CHEMISTRY, MEDICINAL | SCIE | Q4 | — | 45/59 |
| 2015 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q3 | — | 100/163 |
| 2015 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 208/255 |
| 2014 | CHEMISTRY, MEDICINAL | SCIE | Q4 | — | 49/59 |
| 2014 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q3 | — | 107/157 |
| 2014 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 215/255 |
| 2013 | CHEMISTRY, MEDICINAL | SCIE | Q4 | — | 50/58 |
| 2013 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q3 | — | 102/148 |
| 2013 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 207/256 |
| 2012 | CHEMISTRY, MEDICINAL | SCIE | Q4 | — | 51/59 |
| 2012 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q3 | — | 98/152 |
| 2012 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 208/261 |
| 2011 | CHEMISTRY, MEDICINAL | SCIE | Q4 | — | 53/59 |
| 2011 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q3 | — | 94/154 |
| 2011 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 207/261 |
| 2010 | CHEMISTRY, MEDICINAL | SCIE | Q4 | — | 46/54 |
| 2010 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q3 | — | 85/147 |
| 2010 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 205/252 |
| 2009 | CHEMISTRY, MEDICINAL | SCIE | Q4 | — | 37/46 |
| 2009 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q3 | — | 89/140 |
| 2009 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 198/237 |
| 2008 | CHEMISTRY, MEDICINAL | SCIE | Q4 | — | 33/41 |
| 2008 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q3 | — | 77/127 |
| 2008 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 186/219 |
| 2007 | CHEMISTRY, MEDICINAL | SCIE | Q4 | — | 34/41 |
| 2007 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q3 | — | 78/128 |
| 2007 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 176/205 |
| 2006 | CHEMISTRY, MEDICINAL | SCIE | Q4 | — | 33/35 |
| 2006 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q3 | — | 86/124 |
| 2006 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 183/199 |
| 2005 | CHEMISTRY, MEDICINAL | SCIE | Q4 | — | 32/34 |
| 2005 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q3 | — | 81/125 |
| 2005 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 171/193 |
| 2004 | CHEMISTRY, MEDICINAL | SCIE | Q4 | — | 33/36 |
| 2004 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q3 | — | 79/125 |
| 2004 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 165/187 |
| 2003 | CHEMISTRY, MEDICINAL | SCIE | Q4 | — | 29/37 |
| 2003 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q3 | — | 67/123 |
| 2003 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 151/185 |
| 2002 | CHEMISTRY, MEDICINAL | SCIE | Q4 | — | 28/35 |
| 2002 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q3 | — | 61/119 |
| 2002 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 147/188 |
| 2001 | CHEMISTRY, MEDICINAL | SCIE | Q4 | — | 35/36 |
| 2001 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q3 | — | 81/118 |
| 2001 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 168/186 |
| 2000 | CHEMISTRY, MEDICINAL | SCIE | Q4 | — | 31/35 |
| 2000 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q3 | — | 73/118 |
| 2000 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 163/181 |
| 1999 | CHEMISTRY | SCIE | Q3 | — | 78/121 |
| 1999 | CHEMISTRY, MEDICINAL | SCIE | Q4 | — | 27/30 |
| 1999 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 153/175 |
| 1998 | CHEMISTRY | SCIE | Q3 | — | 81/126 |
| 1998 | CHEMISTRY, MEDICINAL | SCIE | Q4 | — | 28/30 |
| 1998 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 152/178 |
| 1997 | CHEMISTRY | SCIE | Q3 | — | 76/111 |
| 1997 | CHEMISTRY, MEDICINAL | SCIE | Q4 | — | 25/28 |
| 1997 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 135/157 |